BEERSE, Belgium, October 15, 2013 /PRNewswire/ --
Janssen-Cilag International NV (Janssen), today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination......
More...
